Global Neurology Academy
The Global Neurology Academy (GNA) Series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
1-15 of 33
- CME/CE In-Person & Virtual Event
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
September 30, 2026
Orlando, Florida When Movements Steal Lives: TD Burden, Stigma, and the Therapeutic Alliance
MinuteCE®When Movements Steal Lives: TD Burden, Stigma, and the Therapeutic Alliance
Tracy Hicks, DNP, MBA
Closing the Gap: Equity, Disparities, and Access to TD Diagnosis and Care
MinuteCE®Closing the Gap: Equity, Disparities, and Access to TD Diagnosis and Care
Tracy Hicks, DNP, MBA
Melissa Moody, MD
From “EPS” to Personalized TD Treatment: Matching VMAT2 MOA to the Patient
MinuteCE®From “EPS” to Personalized TD Treatment: Matching VMAT2 MOA to the Patient
Tracy Hicks, DNP, MBA
Melissa Moody, MD
VMAT2 in the Real World: Recently Presented Clinical Data That Should Change TD Practice
MinuteCE®VMAT2 in the Real World: Recently Presented Clinical Data That Should Change TD Practice
- advertisement
Treating the Complex Patient: TD Management in Older Adults and Medically Fragile Populations
MinuteCE®Treating the Complex Patient: TD Management in Older Adults and Medically Fragile Populations
Tracy Hicks, DNP, MBA
Melissa Moody, MD
The 15-Minute Med Check: Making AIMS and TD Screening Routine in Psychiatry
MinuteCE®The 15-Minute Med Check: Making AIMS and TD Screening Routine in Psychiatry
Tracy Hicks, DNP, MBA
Melissa Moody, MD
Not All VMAT2s Are the Same: Understanding the PK/PD Differences
MinuteCE®Not All VMAT2s Are the Same: Understanding the PK/PD Differences
Tracy Hicks, DNP, MBA
Melissa Moody, MD
From Evidence to Everyday Practice: Using Real-World Data to Refine TD Algorithms
MinuteCE®From Evidence to Everyday Practice: Using Real-World Data to Refine TD Algorithms
Tracy Hicks, DNP, MBA
Melissa Moody, MD
Subtle vs Syndromic: Distinguishing TD from Other DIMDs in the Neuro Clinic
MinuteCE®Subtle vs Syndromic: Distinguishing TD from Other DIMDs in the Neuro Clinic
Tracy Hicks, DNP, MBA
Melissa Moody, MD
- advertisement
Shared Decisions, Real Patients: Patient-Centered TD and Antipsychotic Strategies
MinuteCE®Shared Decisions, Real Patients: Patient-Centered TD and Antipsychotic Strategies
Tracy Hicks, DNP, MBA
Melissa Moody, MD
FXIa Remix! Keeping the Flow Without Missing a Beat
CME/CEFXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
CME/CE Broadcast ReplayEmerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD
Andrew G. Lee, MD
Valerie Biousse, MD
